Comparison of Health Canada and the Patented Medicine Prices Review Board and/or Prescrire International on a drug-by-drug level, first in class drugs
| Patented Medicine Prices Review Board/Prescrire International | ||
|---|---|---|
| Innovative | Not innovative | |
| Health Canada | ||
| Priority review | 8 | 6 |
| Standard review | 2 | 17 |
Positive predictive value=57.1% (95% CI 28.9% to 82.2%).
Negative predictive value=89.5% (95% CI 66.8% to 98.4%).